utah778/iStock via Getty Images While we maintain a strong focus on individual stock selection, we of course monitor the macroeconomic backdrop with an eye toward potential impacts on the companies in which we invest. Fund strategy Invests in companies that are large enough to deliver relative stability but still offer the potential to deliver significant growth opportunities Aims to identify qual...
utah778/iStock via Getty Images While we maintain a strong focus on individual stock selection, we of course monitor the macroeconomic backdrop with an eye toward potential impacts on the companies in which we invest. Fund strategy Invests in companies that are large enough to deliver relative stability but still offer the potential to deliver significant growth opportunities Aims to identify quality growth companies that are innovative, operate within a favorable market structure with high barriers to entry and enjoy structural growth tailwinds Benefits from a dedicated internal analyst team specializing in small- and mid-cap investing that follows an intensive, bottom-up approach to stock selection Expense ratio Share class No waiver(gross) With waiver(net) Institutional 0.88% 0.87% A 1.13% 1.12% Click to enlarge From the fund's most recent prospectus. Net expense ratio reflects a contractual fee waiver/expense reimbursement through 12/31/2026, unless sooner terminated at the sole discretion of the fund's board. Fund performance Institutional Class shares of Columbia Select Mid Cap Growth Fund ( CLSPX ) returned -3.22% for the period ending March 31, 2026. The fund's benchmark, the Russell Midcap Growth Index, returned -6.35% during the same period. Stock selection within the industrials and information technology sectors led positive contributions to relative performance, while positioning in communication services weighed most heavily on returns. For monthly performance information, please check online at Financial Professionals | Columbia Threadneedle Investments US . Average annual total returns (%) as of March 31, 2026 Columbia Select Mid Cap Growth Fund 3-mon. 1-year 3-year 5-year 10-year Institutional Class -3.22 23.92 15.80 6.15 11.84 Class A without sales charge -3.25 23.61 15.50 5.89 11.57 Class A with 5.75% maximum sales charge -8.80 16.48 13.25 4.64 10.91 Russell Midcap Growth Index -6.35 9.56 12.74 5.37 11.69 Russell Midcap Index 1.29 15.98 13.33 7.26...
体育数据巨头Sportradar Group AG正面临证券欺诈集体诉讼。此前做空机构指控该公司明知故犯地与黑市赌博运营商合作以增加收入，导致股价暴跌逾22%，市值蒸发约8亿美元。 诉讼已提交至美国纽约南区联邦地区法院。被告包括Sportradar及首席执行官Carsten Koerl等高管，依据1934年《证券交易法》提出索赔。诉讼覆盖在2024年11月7日至2026年4月21日期间购买该公司A...
The iShares U.S. Aerospace & Defense ETF (NYSEARCA:ITA) is sitting on a 34% one-year gain heading into June, with shares at roughly $235 and $13.5 billion in net assets. Two events in the next four weeks will largely decide whether ITA keeps running: the Pentagon’s FY2027 budget moving through Congress, and the June 29 Honeywell ... ITA Investors: Watch These Two Events Over the Next 30 Days
The iShares U.S. Aerospace & Defense ETF (NYSEARCA:ITA) is sitting on a 34% one-year gain heading into June, with shares at roughly $235 and $13.5 billion in net assets. Two events in the next four weeks will largely decide whether ITA keeps running: the Pentagon’s FY2027 budget moving through Congress, and the June 29 Honeywell ... ITA Investors: Watch These Two Events Over the Next 30 Days
The effective U.S. national debt just crashed through $100 trillion for the first time in history, and now stands at an extraordinary 400% of annual gross domestic product — but almost nobody seems to care.
The effective U.S. national debt just crashed through $100 trillion for the first time in history, and now stands at an extraordinary 400% of annual gross domestic product — but almost nobody seems to care.
Klaus Vedfelt/DigitalVision via Getty Images Investment Overview I shared my first bullish take on Tango Therapeutics, Inc. ( TNGX ) with Seeking Alpha readers back in January 2024 , and the stock is up nearly 150% since. In subsequent notes in September 2024 and January 2025 , I also gave stock Buy ratings, although by January 2025, the stock had sunk in value from $12.5 (in Jan 2024) to <$3 per ...
Klaus Vedfelt/DigitalVision via Getty Images Investment Overview I shared my first bullish take on Tango Therapeutics, Inc. ( TNGX ) with Seeking Alpha readers back in January 2024 , and the stock is up nearly 150% since. In subsequent notes in September 2024 and January 2025 , I also gave stock Buy ratings, although by January 2025, the stock had sunk in value from $12.5 (in Jan 2024) to <$3 per share, down <75% since my first Buy rating. If Tango had tested my faith until then, it has rewarded it handsomely since, as stock now trades at $31 per share, up >625% since January 2025. My last call on the company was, in fact, a Hold rating , however, issued in March this year - shares are up >80% since. On a 5-day basis, shares are up >45% in value after Tango shared : positive initial data from its ongoing Phase 1/2 study of vopimetostat, an investigational PRMT5 inhibitor with first- and best-in-class potential, in combination with Revolution Medicines’ RAS(ON) inhibitors in patients with MTAP-deleted and RAS-mutant metastatic pancreatic ductal adenocarcinoma (PDAC). In the first reported data from the clinical combinations of our PRMT5 inhibitor vopimetostat and RAS(ON) inhibitors, we saw extremely encouraging early results, with 92% of patients with PDAC in the vopimetostat plus daraxonrasib arm achieving an objective response, supporting the preclinical data showing synergistic activity of PRMT5 + RAS inhibition. Readers may be aware that Revolution Medicines ( RVMD ) stock is also enjoying a stellar year, triggered by the success of daraxonrasib, its lead candidate. As I discussed in a note on Revolution last week, the company shared data from a Phase 3 study of daraxonrasib of patients with previously treated metastatic pancreatic cancer, showing a median overall survival ("OS") of 13.2 months, compared to 6.6 months for chemotherapy, the current standard of care. Revolution stock has surged by >250% on a 12-month basis as increasingly impressive daraxonrasib da...
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how software development stocks fared in Q1, starting with Bandwidth (NASDAQ:BAND).
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how software development stocks fared in Q1, starting with Bandwidth (NASDAQ:BAND).
Speculation has intensified around a potential merger between Tesla (NasdaqGS:TSLA) and SpaceX, focused on shared chip manufacturing and AI infrastructure projects. SpaceX is preparing for a record-breaking IPO, and recent amendments to its S-1 filing reference possible future tie ups with Tesla. Institutional investors are actively debating what a combined structure could mean for governance, cap...
Speculation has intensified around a potential merger between Tesla (NasdaqGS:TSLA) and SpaceX, focused on shared chip manufacturing and AI infrastructure projects. SpaceX is preparing for a record-breaking IPO, and recent amendments to its S-1 filing reference possible future tie ups with Tesla. Institutional investors are actively debating what a combined structure could mean for governance, capital allocation, and shareholder outcomes at both companies. Tesla, best known for its electric...
With fears about an over-reliance on the goalscoring captain, Tuchel needs more from his other attackers If Thomas Tuchel requires proof there are worse things to be than the Harry Kane team, he need only hear how underwhelming the future looked when an England second string bid farewell to the 2014 World Cup with a desperate 0-0 draw against Costa Rica in Belo Horizonte. Those were dark times. En...
With fears about an over-reliance on the goalscoring captain, Tuchel needs more from his other attackers If Thomas Tuchel requires proof there are worse things to be than the Harry Kane team, he need only hear how underwhelming the future looked when an England second string bid farewell to the 2014 World Cup with a desperate 0-0 draw against Costa Rica in Belo Horizonte. Those were dark times. England’s race was run after defeats in their first two group games in Brazil and the worry for the Football Association was that the humiliations no longer felt like a surprise. Continue reading...
Key PointsDavid M. Boitano acquired 10,000 shares at a weighted-average price of $34.77 per share, for a total transaction value of approximately $348,000, on June 4, 2026.
Key PointsDavid M. Boitano acquired 10,000 shares at a weighted-average price of $34.77 per share, for a total transaction value of approximately $348,000, on June 4, 2026.
jetcityimage Vera Bradley ( VRA ) continues to expand beyond handbags into a broader lifestyle brand. The latest foray is a new licensing partnership with Li & Fung that extends the existing collaboration into several apparel categories, with an initial focus on tops and outerwear. The new apparel line will bring Vera Bradley's ( VRA ) signature prints and design language into apparel, according t...
jetcityimage Vera Bradley ( VRA ) continues to expand beyond handbags into a broader lifestyle brand. The latest foray is a new licensing partnership with Li & Fung that extends the existing collaboration into several apparel categories, with an initial focus on tops and outerwear. The new apparel line will bring Vera Bradley's ( VRA ) signature prints and design language into apparel, according to Women's Wear Daily. During Vera Bradley's ( VRA ) last earnings conference call, the management team highlighted how IP partnerships remain an important driver of brand heat and commercial success. "Our strategy is to focus on fewer, more impactful, and qualitatively executed IP launches going forward," updated interim CEO Ian Bickley. "The success of this strategy was evidenced by our Peanuts, Lilo and Stitch, and recent Winnie the Pooh collaborations, which achieved excellent social media engagement and strong product sell-through, some of the best results we have ever had," he added. More on Vera Bradley Vera Bradley: A Colorful Turnaround Vera Bradley, Inc. (VRA) Q4 2026 Earnings Call Transcript Vera Bradley outlines $255M–$270M sales plan for FY27 as profitability returns and transformation accelerates Vera Bradley Non-GAAP EPS of $0.09, revenue of $84.89M Seeking Alpha’s Quant Rating on Vera Bradley
Erik Isakson Applied Optoelectronics ( AAOI ) plunged 14% by afternoon trading Tuesday, leading an array of optical networking stocks into the red following a bearish report by Semi Analysis . The report, which was sent out to institutional clients only, indicated the upcoming rollout of co-packaged optics, or CPOs, will likely be delayed. The report stemmed from conversations at Computex last wee...
Erik Isakson Applied Optoelectronics ( AAOI ) plunged 14% by afternoon trading Tuesday, leading an array of optical networking stocks into the red following a bearish report by Semi Analysis . The report, which was sent out to institutional clients only, indicated the upcoming rollout of co-packaged optics, or CPOs, will likely be delayed. The report stemmed from conversations at Computex last week in Taipei, Taiwan. Lumentum ( LITE ) tumbled 8%, Coherent ( COHR ) cratered 11% and Ciena ( CIEN ) fell 7%. In addition, Corning ( GLW ) dropped 9%, and Arista Networks ( ANET ) dipped 3%. Broadcom ( AVGO ) was down 1.5%, and Marvell ( MRVL ) dropped 9%. However, Tae Kim, who interviewed Gilad Shainer , Nvidia's ( NVDA ) senior vice president of networking, at Computex, said the executive did not indicate any delays at all regarding CPO shipments. "We're going to ramp up CPO second half of the year," Shainer said. "And you're going to see more and more CPOs. And we're starting on scale out. And we already mentioned that in the Feynman generation; now we're doing Vera Rubin; next will be Feynman." "We believe that co-packaged optics is the best technology for scale-out," Shainer added. CPOs provide improved network reliability and power efficiency over traditional network switches. It does this by streamlining and eliminating unnecessary interfaces. "The new offerings streamline the signal path for enhanced performance, efficiency, and reliability," said Ashkan Seyedi, a director of product marketing at Nvidia. "These innovations not only set new records in bandwidth and port density but also fundamentally alter the economics and physical design of AI data centers." More on Applied Optoelectronics Lumentum Holdings Inc. (LITE) Presents at Mizuho Technology Conference 2026 Transcript Why I'm Buying The Applied Optoelectronics Dip Lumentum: Too Bright To Short, Too Fully Priced To Chase Ciena prices upsized $2.5B senior convertible debt offering Ciena plans $2B debt offering...